ClinicalTrialsFinder

Glioma, Diffuse Midline, H3K27M-mutant Clinical Trials in Changsha, Hunan

1 recruitingChangsha, Hunan, China

Showing 1–1 of 1 trials

Recruiting

Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:

GliomasGlioma Glioblastoma MultiformeGliomas Harboring IDH1 and/or IDH2 Mutations+3 more
Xiangya Hospital of Central South University500 enrolled1 locationNCT07608003